Back to search results

INSPIRE for Shortness of Breath in Lung Cancer

This study is testing a new program called INSPIRE to help people with lung cancer manage shortness of breath (dyspnea). Dyspnea is a common and difficult symptom for many lung cancer patients. Current treatments often don't provide enough relief, so researchers are looking for better ways to help. INSPIRE is a personalized program that combines different types of support, including behavioral and cognitive-behavioral techniques. This first phase of the study will involve about 10 participants and aims to get feedback from patients and doctors to make the INSPIRE program even better. The main goal is to see what patients think of the program after 4 months.

Study design
This is an interventional study with a planned enrollment of 10 participants. It is an open pilot study, meaning all participants will receive the INSPIRE intervention.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Patient feedback will be measured at 4 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07728773

A Stepped Intervention for Coping With Dyspnea in Patients With Lung Cancer-Phase A (Open Pilot)

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
Massachusetts General Hospital
~10 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:INSPIRE

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Qualitative patient feedback
Measured over 4 months

Conditions

Dyspnea
Lung Cancer (Diagnosis)

Explore related trials

DyspneaLung Carcinoma

NCT07728773

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Mass General Brigham

    Boston, Massachusettsstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Stephen Lo Principal Investigator, PhD
[email protected]
617-726-2000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

adults (age ≥ 18) diagnosed with non-small cell lung cancer or small cell lung cancer
report of at least moderate dyspnea (scoring ≥2 on the Modified Medical Research Council Dyspnea Scale)
≥3 months from cancer diagnosis without plans for surgical treatment for lung cancer
primary cancer care at Mass General Brigham
able to read and respond to questions in English

What this trial measures

  • Qualitative patient feedback4 months

    The investigators will collect the qualitative experience of study patients obtained through exit interviews and feedback.